Holen Sie sich die Stockscreener-App
1.82
0.55%
-0.01
Handel nachbörslich:
1.84
0.02
+1.10%
Schlusskurs vom Vortag:
$1.83
Offen:
$1.84
24-Stunden-Volumen:
556.67K
Relative Volume:
0.24
Marktkapitalisierung:
$68.38M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-144.01M
KGV:
-0.4539
EPS:
-4.01
Netto-Cashflow:
$-113.02M
1W Leistung:
+2.25%
1M Leistung:
+0.55%
6M Leistung:
-57.87%
1J Leistung:
-66.67%
1-Tages-Spanne:
$1.79
$1.84
1-Wochen-Bereich:
$1.79
$1.965
52-Wochen-Spanne:
$1.2905
$13.07
Biomea Fusion Inc Stock (BMEA) Company Profile
Firmenname
Biomea Fusion Inc
Sektor
Branche
Telefon
(650) 980-9099
Adresse
900 MIDDLEFIELD ROAD, REDWOOD CITY
Vergleichen Sie BMEA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BMEA
Biomea Fusion Inc
|
1.82 | 101.50M | 0 | -144.01M | -113.02M | -4.01 |
|
VRTX
Vertex Pharmaceuticals Inc
|
470.13 | 119.21B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.93 | 59.16B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
325.28 | 40.57B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
571.23 | 34.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
295.59 | 29.19B | 3.81B | -644.79M | -669.77M | -6.24 |
Biomea Fusion Inc Stock (BMEA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-03 | Fortgesetzt | Piper Sandler | Overweight |
| 2024-10-09 | Eingeleitet | Edward Jones | Buy |
| 2024-09-27 | Hochstufung | Rodman & Renshaw | Neutral → Buy |
| 2024-09-27 | Hochstufung | Truist | Hold → Buy |
| 2024-08-29 | Eingeleitet | CapitalOne | Overweight |
| 2024-06-11 | Herabstufung | Truist | Buy → Hold |
| 2024-06-07 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-04-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-02-06 | Eingeleitet | Truist | Buy |
| 2023-07-27 | Eingeleitet | Scotiabank | Sector Outperform |
| 2023-06-26 | Herabstufung | Jefferies | Buy → Hold |
| 2023-05-12 | Eingeleitet | Barclays | Overweight |
| 2023-03-29 | Bestätigt | Oppenheimer | Outperform |
| 2023-03-28 | Bestätigt | H.C. Wainwright | Buy |
| 2023-02-24 | Eingeleitet | Citigroup | Buy |
| 2022-06-02 | Fortgesetzt | H.C. Wainwright | Buy |
| 2022-01-12 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-12-17 | Eingeleitet | Oppenheimer | Outperform |
| 2021-05-11 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-11 | Eingeleitet | Jefferies | Buy |
| 2021-05-11 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Biomea Fusion Inc Aktie (BMEA) Neueste Nachrichten
What drives Biomea Fusion Inc. stock priceUnprecedented market success - Autocar Professional
Biomea Fusion Inc. Stock Analysis and ForecastTremendous financial leverage - jammulinksnews.com
What analysts say about Biomea Fusion Inc. stockUnstoppable profit momentum - jammulinksnews.com
Is Biomea Fusion Inc. a good long term investmentUnmatched profit growth - printweek.in
Citigroup Lowers Biomea Fusion Price Target to $9.00 Amid "Buy" Rating - AInvest
Citigroup Has Lowered Expectations for Biomea Fusion (NASDAQ:BMEA) Stock Price - Defense World
What makes Biomea Fusion Inc. stock price move sharplyFree Best Performing Stock Alerts - Newser
How Biomea Fusion Inc. stock performs during market volatilityInsider Level Guidance - Newser
Why Biomea Fusion Inc. stock attracts strong analyst attentionFree Market Analysis Group - Newser
While institutions invested in Biomea Fusion, Inc. (NASDAQ:BMEA) benefited from last week's 15% gain, retail investors stood to gain the most - Yahoo Finance
Want to make yourself less appealing to mosquitoes? Our quiz has surprising ideas - Alaska Public Media
Biomea Fusion, Inc. (NASDAQ:BMEA) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Biomea Fusion’s BMF-219 Study Update: Implications for Investors - TipRanks
Biomea Fusion’s BMF-219 Study: A Potential Game-Changer for Type 2 Diabetes - TipRanks
Oppenheimer & Co. Inc. Buys 78,579 Shares of Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Biomea Fusion’s Phase 2 Trial: A New Hope for Type 1 Diabetes Treatment - TipRanks
Biomea Fusion, Inc.(NasdaqGS: BMEA) dropped from Russell 2000 Index - MarketScreener
Biomea Fusion, Inc.(NasdaqGS: BMEA) added to Russell Microcap Value Index - MarketScreener
HC Wainwright Predicts Stronger Earnings for Biomea Fusion - Defense World
Exchange Traded Concepts LLC Grows Stock Holdings in Biomea Fusion, Inc. (NASDAQ:BMEA) - Defense World
Biomea Fusion stock price target cut to $4 from $18 at H.C. Wainwright By Investing.com - Investing.com South Africa
Biomea Fusion Presents New Preclinical and Clinical Data on Icovamenib at the 85th Scientific Sessions of the American Diabetes Association (ADA) - The Manila Times
Biomea Fusion Closes $37.1M Stock Offering - TipRanks
Biomea Fusion stock falls after announcing public offering - Investing.com Australia
Market Today: Safran's Asset Sale and Biomea Fusion's Stock Offering - GuruFocus
Crude Oil Moves Higher; US Weekly Jobless Claims Decline - Benzinga
Top Midday Decliners - MarketScreener
Biomea Fusion stock falls after announcing public offering By Investing.com - Investing.com South Africa
Biomea Fusion (BMEA) Reports Promising Preclinical Results for W - GuruFocus
Bitdeer, Biomea Fusion, Circle Internet - TradingView
Biomea Fusion (BMEA) Reports Promising Preclinical Results for Weight Loss Study | BMEA Stock News - GuruFocus
Biomea Fusion Reports Preclinical Data for BMF-650, a - GlobeNewswire
Biomea Fusion (BMEA) Receives Reaffirmed Buy Rating by D. Boral Capital | BMEA Stock News - GuruFocus
Biomea Fusion surges 76% following InvestingPro’s April Fair Value alert By Investing.com - Investing.com India
Biomea Fusion Reports Preclinical Data for BMF-650, a Next-Generation Oral GLP-1 Receptor Agonist Candidate, Demonstrating Robust Weight Loss and Appetite Suppression in Obese Non-Human Primates - Yahoo Finance
US Stocks Likely To Open Higher Despite Trump's 'Unconditional Surrender' Call: All Eyes On Powell As Experts Predict Inflation Will Limit Fed's Rate Cut Capacity - Benzinga
Why Beyond Air Shares Are Trading Lower By Over 23%; Here Are 20 Stocks Moving Premarket - Benzinga
Biomea Fusion tumbles on deep-discounted $40 mln equity raise - TradingView
Biomea Fusion Prices $40 Million Offering of Securities - marketscreener.com
Biomea Fusion (BMEA) Launches Public Offering with Warrants | BM - GuruFocus
Biomea Fusion (BMEA) Launches $40M Public Offering, Shares Drop - GuruFocus
Biomea Fusion sinks 25%, prices $40M stock offering (BMEA:NASDAQ) - Seeking Alpha
Diabetes Drug Developer Biomea Fusion Raises $40M in Strategic Public Offering with Warrant Sweetener - Stock Titan
(BMEA) Faces Pricing Challenge with New Offering | BMEA Stock News - GuruFocus
Biomea Fusion Slides After-Hours Following Stock-And-Warrant Offering; Retail Traders See Rebound Ahead - Asianet Newsable
Biomea Fusion Announces Pricing Of Public Offering Of Securities - marketscreener.com
Biomea Fusion Announces Pricing of Public Offering of Securities - GlobeNewswire Inc.
Biomea Fusion launches public offering of common stock and warrants By Investing.com - Investing.com India
Biomea Fusion Launches Public Offering of Securities; Shares Fall After Hours - marketscreener.com
Biomea Fusion tumbles on planned equity offering - TradingView
Finanzdaten der Biomea Fusion Inc-Aktie (BMEA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.51%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):